Holen Sie sich die Stockscreener-App
51.44
1.52%
0.77
Schlusskurs vom Vortag:
$50.67
Offen:
$52
24-Stunden-Volumen:
2.84M
Relative Volume:
1.96
Marktkapitalisierung:
$7.43B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-946.53M
KGV:
-7.384
EPS:
-6.9664
Netto-Cashflow:
$-814.94M
1W Leistung:
+8.78%
1M Leistung:
+6.19%
6M Leistung:
+17.68%
1J Leistung:
+54.01%
1-Tages-Spanne:
$50.24
$53.48
1-Wochen-Bereich:
$46.71
$53.48
52-Wochen-Spanne:
$29.08
$65.00
Vaxcyte Inc Stock (PCVX) Company Profile
Firmenname
Vaxcyte Inc
Sektor
Branche
Telefon
650-837-0111
Adresse
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Compare PCVX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
51.44 | 7.43B | 0 | -946.53M | -814.94M | -6.9664 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Bestätigt | Needham | Buy |
| 2025-09-12 | Eingeleitet | Goldman | Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Eingeleitet | Goldman | Buy |
| 2023-12-07 | Eingeleitet | Mizuho | Buy |
| 2023-04-18 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-03 | Bestätigt | Needham | Buy |
| 2022-12-15 | Eingeleitet | Guggenheim | Buy |
| 2022-11-17 | Eingeleitet | BTIG Research | Buy |
| 2021-12-29 | Fortgesetzt | Jefferies | Buy |
| 2021-06-24 | Fortgesetzt | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | BofA Securities | Buy |
| 2020-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-07-07 | Eingeleitet | Needham | Buy |
Alle ansehen
Vaxcyte Inc Aktie (PCVX) Neueste Nachrichten
Vaxcyte president and CFO sells $530,000 in company stock - Investing.com UK
Vaxcyte CEO Grant Pickering sells $1.28m in stock - Investing.com UK
Vaxcyte CEO Grant Pickering sells $1.28m in stock By Investing.com - Investing.com India
Vaxcyte president and CFO sells $530,000 in company stock By Investing.com - Investing.com Nigeria
Vaxcyte (NASDAQ: PCVX) CEO sells 24,461 shares under 10b5-1 plan - Stock Titan
[144] Vaxcyte, Inc. SEC Filing - Stock Titan
UBS Lists Multiple PCVX Share Lots for Sale (NASDAQ: PCVX) - Stock Titan
Vaxcyte Inc (PCVX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vaxcyte Inc (PCVX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vaxcyte Inc (PCVX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vaxcyte Inc (PCVX) Institutional Confidence - TradingKey
Vaxcyte Inc (PCVX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vaxcyte Inc (PCVX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vaxcyte Inc (PCVX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vaxcyte (PCVX) Conducts Initial Dosage for VAX-A1 Phase 1 Study - Insider Monkey
Vaxcyte Stockinsider equity awards follow annual meeting - AD HOC NEWS
Avoiding Lag: Real-Time Signals in (PCVX) Movement - Stock Traders Daily
Vaxcyte (NASDAQ: PCVX) director receives RSU and stock option awards - Stock Titan
Vaxcyte (PCVX) director granted 2,194 RSUs and 11,034 options in equity award - Stock Titan
[Form 4] Vaxcyte, Inc. Insider Trading Activity - Stock Titan
Equity awards to Vaxcyte (PCVX) director Lee Jacks detailed - Stock Titan
Vaxcyte (PCVX) director receives RSU and option grants with 2027 vesting - Stock Titan
Vaxcyte (NASDAQ: PCVX) director receives RSU and stock option grants - Stock Titan
Vaxcyte (PCVX) director granted RSUs and 11,389-share stock option - Stock Titan
Vaxcyte (NASDAQ: PCVX) director receives RSUs and stock options grant - Stock Titan
Vaxcyte (PCVX) investors re-elect directors and approve pay and Deloitte at 2026 meeting - Stock Titan
Vaxcyte Inc (PCVX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Vaxcyte (PCVX) AGM 2026 Summary - Quartr
PCVX: All proposals passed with strong support and no shareholder questions were raised - TradingView
PCVX: All board proposals passed with a strong quorum and no shareholder questions raised - TradingView
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
TD Asset Management Inc Cuts Stock Holdings in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte, Inc. (PCVX) Stock Analysis: A Biotech With A Promising 130% Upside Potential - DirectorsTalk Interviews
Norges Bank Invests $56.70 Million in Vaxcyte, Inc. $PCVX - MarketBeat
Operating expenses (excl. COGS) of Vaxcyte, Inc. – XETR:5VA - TradingView
Diluted shares outstanding of Vaxcyte, Inc. – XETR:5VA - TradingView
Average basic shares outstanding of Vaxcyte, Inc. – XETR:5VA - TradingView
Net current asset value per share of Vaxcyte, Inc. – XETR:5VA - TradingView
Total assets of Vaxcyte, Inc. – XETR:5VA - TradingView
EBIT of Vaxcyte, Inc. – XETR:5VA - TradingView
EBITDA of Vaxcyte, Inc. – XETR:5VA - TradingView
EBIT per share of Vaxcyte, Inc. – XETR:5VA - TradingView
Vaxcyte, Inc. Balance Sheet – XETR:5VA - TradingView
Vaxcyte, Inc. Earnings and Revenue – XETR:5VA - TradingView
Vaxcyte, Inc. Statistics – XETR:5VA - TradingView
Vaxcyte, Inc. Dividends – XETR:5VA - TradingView
Discipline and Rules-Based Execution in PCVX Response - Stock Traders Daily
Westfield Capital Management Co. LP Lowers Position in Vaxcyte, Inc. $PCVX - MarketBeat
PCVX News | VAXCYTE INC (NASDAQ:PCVX) - ChartMill
Does Vaxcyte’s First-in-Human Group A Strep Trial Reshape The Bull Case For Vaxcyte (PCVX)? - simplywall.st
Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Vaxcyte (PCVX) and BeOne Medicines (ONC) - The Globe and Mail
Finanzdaten der Vaxcyte Inc-Aktie (PCVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):